rs141088433

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001164507.2(NEB):​c.10347+6C>T variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00314 in 1,613,470 control chromosomes in the GnomAD database, including 77 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0088 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 67 hom. )

Consequence

NEB
NM_001164507.2 splice_donor_region, intron

Scores

2
Splicing: ADA: 0.00001449
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.763
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-151626996-G-A is Benign according to our data. Variant chr2-151626996-G-A is described in ClinVar as [Benign]. Clinvar id is 257718.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-151626996-G-A is described in Lovd as [Benign]. Variant chr2-151626996-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0088 (1340/152244) while in subpopulation EAS AF= 0.0521 (270/5186). AF 95% confidence interval is 0.047. There are 10 homozygotes in gnomad4. There are 673 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NEBNM_001164507.2 linkuse as main transcriptc.10347+6C>T splice_donor_region_variant, intron_variant ENST00000427231.7
NEBNM_001164508.2 linkuse as main transcriptc.10347+6C>T splice_donor_region_variant, intron_variant ENST00000397345.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NEBENST00000397345.8 linkuse as main transcriptc.10347+6C>T splice_donor_region_variant, intron_variant 5 NM_001164508.2 P5P20929-2
NEBENST00000427231.7 linkuse as main transcriptc.10347+6C>T splice_donor_region_variant, intron_variant 5 NM_001164507.2 A2P20929-3
NEBENST00000409198.5 linkuse as main transcriptc.9618+6C>T splice_donor_region_variant, intron_variant 5 P20929-4

Frequencies

GnomAD3 genomes
AF:
0.00879
AC:
1337
AN:
152126
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0221
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00675
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0529
Gnomad SAS
AF:
0.00414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00526
GnomAD3 exomes
AF:
0.00770
AC:
1915
AN:
248838
Hom.:
35
AF XY:
0.00682
AC XY:
921
AN XY:
134968
show subpopulations
Gnomad AFR exome
AF:
0.0231
Gnomad AMR exome
AF:
0.0121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0548
Gnomad SAS exome
AF:
0.00376
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.00447
GnomAD4 exome
AF:
0.00255
AC:
3733
AN:
1461226
Hom.:
67
Cov.:
31
AF XY:
0.00244
AC XY:
1777
AN XY:
726878
show subpopulations
Gnomad4 AFR exome
AF:
0.0238
Gnomad4 AMR exome
AF:
0.0113
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0408
Gnomad4 SAS exome
AF:
0.00369
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000114
Gnomad4 OTH exome
AF:
0.00570
GnomAD4 genome
AF:
0.00880
AC:
1340
AN:
152244
Hom.:
10
Cov.:
32
AF XY:
0.00904
AC XY:
673
AN XY:
74442
show subpopulations
Gnomad4 AFR
AF:
0.0222
Gnomad4 AMR
AF:
0.00674
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0521
Gnomad4 SAS
AF:
0.00415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000176
Gnomad4 OTH
AF:
0.00568
Alfa
AF:
0.00384
Hom.:
3
Bravo
AF:
0.0111
Asia WGS
AF:
0.0160
AC:
56
AN:
3478
EpiCase
AF:
0.000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 24, 2017Variant summary: The NEB c.10347+6C>T variant involves the alteration of a non-conserved intronic nucleotide and 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 925/120680 control chromosomes (19 homozygotes) at a frequency of 0.0076649, which is approximately 2 times the estimated maximal expected allele frequency of a pathogenic NEB variant (0.0035355), suggesting this variant is likely a benign polymorphism. The variant is more common in East Asian sub-population with allele frequency of 5.4% (464/8590 chromosomes). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Therefore, the variant of interest has been classified as Benign. -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJun 27, 2019- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
not specified Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxJul 08, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Nemaline myopathy 2 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.81
DANN
Benign
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000014
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141088433; hg19: chr2-152483510; API